A spleen tyrosine kinase inhibitor attenuates the proliferation and migration of vascular smooth muscle cells
Abstract Background Pathologic vascular smooth muscle cell (VSMC) proliferation and migration after vascular injury promotes the development of occlusive vascular disease. Therefore, an effective chemical agent to suppress aberrant proliferation and migration of VSMCs can be a potential therapeuti...
Guardado en:
Autores principales: | Seo,Hyang‑Hee, Kim,Sang Woo, Lee,Chang Youn, Lim,Kyu Hee, Lee,Jiyun, Choi,Eunhyun, Lim,Soyeon, Lee,Seahyoung, Hwang,Ki‑Chul |
---|---|
Lenguaje: | English |
Publicado: |
Sociedad de Biología de Chile
2017
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602017000100403 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Spleen Tyrosine Kinase Inhibitor TAK-659 Prevents Splenomegaly and Tumor Development in a Murine Model of Epstein-Barr Virus-Associated Lymphoma
por: Osman Cen, et al.
Publicado: (2018) -
S100A8 inhibits PDGF-induced proliferation of airway smooth muscle cells dependent on the receptor for advanced glycation end-products
por: Xu,Yu‑Dong, et al.
Publicado: (2017) -
Naked physically synthesized gold nanoparticles affect migration, mitochondrial activity, and proliferation of vascular smooth muscle cells
por: Lo HM, et al.
Publicado: (2018) -
TMPYP4 exerted antitumor effects in human cervical cancer cells through activation of p38 mitogen-activated protein kinase
por: Cheng,Ming‑Jun, et al.
Publicado: (2017) -
Spleen Tyrosine Kinase Is a Critical Regulator of Neutrophil Responses to <italic toggle="yes">Candida</italic> Species
por: Paige E. Negoro, et al.
Publicado: (2020)